News shared by:

336 Articles
16 Feb 2019
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement

Arvelle Therapeutics to receive rights to develop and commercialize cenobamate, an investigational antiepileptic drug developed by SK Biopharmaceuticals, in Europe. SK Biopharmaceuticals to...

16 Feb 2019
Glenmark Pharmaceuticals to spin off innovation business into new company in US

Drugmaker Glenmark Pharmaceuticals Ltd has decided to spin off its innovation business into a new company in the United States, a move that will get it closer to the research-led ecosystem....

14 Feb 2019
FDA cracks down on dietary supplements marketed for Alzheimer disease

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices. The US Food and...

14 Feb 2019
Post-EU FMD deadline

Partner connectivity will be an immediate and ongoing challenge beyond the deadline and several pharma companies are likely to break agreements with current suppliers through breach of contract...

12 Feb 2019
Overview of GMP Requirements for Radiopharmaceuticals

The new WHO and IAEA guidelines are intended to provide a general overview of GMP(Good Manufacturing Practice) requirements for radiopharmaceuticals. While the basics...

12 Feb 2019
Samsung Bioepis announced agreement with C-Bridge Capital

Samsung Bioepis announced in a February 11, 2019 press release that it will expand in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar...

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×